Market Research Life Sciences Market Research Medical Devices Market Research Diabetes Market Research

Diabetes Assays Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

Best Price Guarantee Length Publisher Published Date SKU
from $4,000 92 Pages GlobalData May, 2023 GBDT18015725
Best Price Guarantee
Price from $4,000
Length 92 Pages
Publisher GlobalData
Published Date May, 2023
SKU GBDT18015725

Diabetes Assays Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update


Summary

GlobalData's Medical Devices sector report, “Diabetes Assays Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Diabetes Assays pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.Diabetes Assays comprises of C-Peptide Assay, Glycated Hemoglobin (HbA1c) Lab Assay, Glycated Hemoglobin (HbA1c) Point of care (POC) Assay, Insulin Assay and Fasting Glucose Assay.

Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Diabetes Assays under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Diabetes Assays and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Diabetes Assays under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


    • 2 Table of Contents
    1 About GlobalData
    2 Table of Contents
    2.1 List of Tables
    2.2 List of Figures
    3 Introduction
    3.1 Diabetes Assays Overview
    4 Products under Development
    4.1 Diabetes Assays - Pipeline Products by Stage of Development
    4.2 Diabetes Assays - Pipeline Products by Segment
    4.3 Diabetes Assays - Pipeline Products by Territory
    4.4 Diabetes Assays - Pipeline Products by Regulatory Path
    4.5 Diabetes Assays - Pipeline Products by Estimated Approval Date
    5 Diabetes Assays - Pipeline Products under Development by Companies
    5.1 Diabetes Assays Companies - Pipeline Products by Stage of Development
    5.2 Diabetes Assays – Companies Pipeline Products by Stage of Development
    6 Diabetes Assays Companies and Product Overview
    6.1 Abcodia Ltd Company Overview
    6.1.1 Abcodia Ltd Pipeline Products & Ongoing Clinical Trials Overview
    6.2 Adaptive Biotechnologies Corp Company Overview
    6.2.1 Adaptive Biotechnologies Corp Pipeline Products & Ongoing Clinical Trials Overview
    6.3 Adipomics Inc Company Overview
    6.3.1 Adipomics Inc Pipeline Products & Ongoing Clinical Trials Overview
    6.4 Aditxt Inc Company Overview
    6.4.1 Aditxt Inc Pipeline Products & Ongoing Clinical Trials Overview
    6.5 Alfa Wassermann Inc Company Overview
    6.5.1 Alfa Wassermann Inc Pipeline Products & Ongoing Clinical Trials Overview
    6.6 AmideBio, LLC Company Overview
    6.6.1 AmideBio, LLC Pipeline Products & Ongoing Clinical Trials Overview
    6.7 Aura Biotechnologies Pvt Ltd Company Overview
    6.7.1 Aura Biotechnologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
    6.8 Beckman Coulter Inc Company Overview
    6.8.1 Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview
    6.9 Biocrates Life Sciences AG Company Overview
    6.9.1 Biocrates Life Sciences AG Pipeline Products & Ongoing Clinical Trials Overview
    6.10 BioDesign Institute at Arizona State University Company Overview
    6.10.1 BioDesign Institute at Arizona State University Pipeline Products & Ongoing Clinical Trials Overview
    6.11 CellCarta Precision Medicine Inc Company Overview
    6.11.1 CellCarta Precision Medicine Inc Pipeline Products & Ongoing Clinical Trials Overview
    6.12 Confer Health Inc Company Overview
    6.12.1 Confer Health Inc Pipeline Products & Ongoing Clinical Trials Overview
    6.13 Drexel University Company Overview
    6.13.1 Drexel University Pipeline Products & Ongoing Clinical Trials Overview
    6.14 ELITechGroup Inc Company Overview
    6.14.1 ELITechGroup Inc Pipeline Products & Ongoing Clinical Trials Overview
    6.15 Enable Biosciences Inc Company Overview
    6.15.1 Enable Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
    6.16 FibroStatin SL Company Overview
    6.16.1 FibroStatin SL Pipeline Products & Ongoing Clinical Trials Overview
    6.17 G Medical Innovations Holdings Ltd Company Overview
    6.17.1 G Medical Innovations Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview
    6.18 GATC DB Care Corp Company Overview
    6.18.1 GATC DB Care Corp Pipeline Products & Ongoing Clinical Trials Overview
    6.19 Gelteq Pty Ltd Company Overview
    6.19.1 Gelteq Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
    6.20 Genesis Detection Systems, Inc. Company Overview
    6.20.1 Genesis Detection Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
    6.21 Guangzhou Wondfo Biotech Co Ltd Company Overview
    6.21.1 Guangzhou Wondfo Biotech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
    6.22 Helmholtz Centre for Infection Research Company Overview
    6.22.1 Helmholtz Centre for Infection Research Pipeline Products & Ongoing Clinical Trials Overview
    6.23 Hemex Health Inc Company Overview
    6.23.1 Hemex Health Inc Pipeline Products & Ongoing Clinical Trials Overview
    6.24 Human Cell Design SAS Company Overview
    6.24.1 Human Cell Design SAS Pipeline Products & Ongoing Clinical Trials Overview
    6.25 IntraMed Diagnostics, LLC Company Overview
    6.25.1 IntraMed Diagnostics, LLC Pipeline Products & Ongoing Clinical Trials Overview
    6.26 Janssen Diagnostics LLC Company Overview
    6.26.1 Janssen Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
    6.27 Johns Hopkins University Company Overview
    6.27.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
    6.28 L2 Diagnostics LLC Company Overview
    6.28.1 L2 Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
    6.29 Matter Diagnostics Company Overview
    6.29.1 Matter Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
    6.30 MediSure Canada Inc Company Overview
    6.30.1 MediSure Canada Inc Pipeline Products & Ongoing Clinical Trials Overview
    6.31 Mellitus LLC Company Overview
    6.31.1 Mellitus LLC Pipeline Products & Ongoing Clinical Trials Overview
    6.32 Numares AG Company Overview
    6.32.1 Numares AG Pipeline Products & Ongoing Clinical Trials Overview
    6.33 Peri Rx Inc Company Overview
    6.33.1 Peri Rx Inc Pipeline Products & Ongoing Clinical Trials Overview
    6.34 PortaScience Inc Company Overview
    6.34.1 PortaScience Inc Pipeline Products & Ongoing Clinical Trials Overview
    6.35 Precision Diabetes LLC Company Overview
    6.35.1 Precision Diabetes LLC Pipeline Products & Ongoing Clinical Trials Overview
    6.36 Protagen AG Company Overview
    6.36.1 Protagen AG Pipeline Products & Ongoing Clinical Trials Overview
    6.37 Queen Mary University of London Company Overview
    6.37.1 Queen Mary University of London Pipeline Products & Ongoing Clinical Trials Overview
    6.38 QuickCheck Health Inc Company Overview
    6.38.1 QuickCheck Health Inc Pipeline Products & Ongoing Clinical Trials Overview
    6.39 Sebia SA Company Overview
    6.39.1 Sebia SA Pipeline Products & Ongoing Clinical Trials Overview
    6.40 Sera Prognostics Inc Company Overview
    6.40.1 Sera Prognostics Inc Pipeline Products & Ongoing Clinical Trials Overview
    6.41 Singulex Inc Company Overview
    6.41.1 Singulex Inc Pipeline Products & Ongoing Clinical Trials Overview
    6.42 SomaLogic Inc Company Overview
    6.42.1 SomaLogic Inc Pipeline Products & Ongoing Clinical Trials Overview
    6.43 The Forsyth Institute Company Overview
    6.43.1 The Forsyth Institute Pipeline Products & Ongoing Clinical Trials Overview
    6.44 University of Canterbury Company Overview
    6.44.1 University of Canterbury Pipeline Products & Ongoing Clinical Trials Overview
    6.45 University of Colorado Company Overview
    6.45.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview
    6.46 University of Florida Company Overview
    6.46.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview
    6.47 University of Newcastle Company Overview
    6.47.1 University of Newcastle Pipeline Products & Ongoing Clinical Trials Overview
    6.48 University of Oxford Company Overview
    6.48.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview
    6.49 University of South Florida Company Overview
    6.49.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
    6.50 University of Strathclyde Company Overview
    6.50.1 University of Strathclyde Pipeline Products & Ongoing Clinical Trials Overview
    6.51 Vactech Oy Company Overview
    6.51.1 Vactech Oy Pipeline Products & Ongoing Clinical Trials Overview
    6.52 Wave 80 Biosciences Inc Company Overview
    6.52.1 Wave 80 Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
    6.53 Xhale Inc Company Overview
    6.53.1 Xhale Inc Pipeline Products & Ongoing Clinical Trials Overview
    6.54 Yaathum Biotech Pvt Ltd Company Overview
    6.54.1 Yaathum Biotech Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
    7 Diabetes Assays- Recent Developments
    7.1 Apr 25, 2023: Lifespin partners with Leipzig Research Center for Civilization Diseases (LIFE) to explore metabolic correlations with obesity and diabetes
    7.2 Jan 24, 2023: Diabetes Patients See Significant Benefit from Value-Based, Total Care Model, According to New Data from agilon health
    7.3 Dec 14, 2022: Researchers receive $3.2 Million for diabetes treatment testing
    7.4 Sep 01, 2022: NuraLogix researchers develop AI models for pre-diabetes risk prediction
    7.5 Jul 25, 2022: Beckman Coulter partners with Mass General and BARDA to identify severe pediatric infections in emergency departments
    7.6 Jul 12, 2022: Aspire & USF Pass $10M in ticket & donation revenue
    8 Appendix
    8.1 Methodology
    8.2 About GlobalData
    8.3 Contact Us
    8.4 Disclaimer
    2.1 List of Tables
    Table 1: Diabetes Assays - Pipeline Products by Stage of Development
    Table 2: Diabetes Assays - Pipeline Products by Segment
    Table 3: Diabetes Assays - Pipeline Products by Territory
    Table 4: Diabetes Assays - Pipeline Products by Regulatory Path
    Table 5: Diabetes Assays - Pipeline Products by Estimated Approval Date
    Table 6: Diabetes Assays Companies - Pipeline Products by Stage of Development
    Table 7: Diabetes Assays – Companies Pipeline Products by Stage of Development
    Table 8: Abcodia Ltd Pipeline Products & Ongoing Clinical Trials Overview
    Table 9: Molecular Biomarker - Diabetes - Product Status
    Table 10: Molecular Biomarker - Diabetes - Product Description
    Table 11: Adaptive Biotechnologies Corp Pipeline Products & Ongoing Clinical Trials Overview
    Table 12: Pre - Symptomatic Biomarker - Type 1 Diabetes - Product Status
    Table 13: Pre - Symptomatic Biomarker - Type 1 Diabetes - Product Description
    Table 14: Adipomics Inc Pipeline Products & Ongoing Clinical Trials Overview
    Table 15: Diagnostic Test - Gestational Pre-Diabetes - Product Status
    Table 16: Diagnostic Test - Gestational Pre-Diabetes - Product Description
    Table 17: Aditxt Inc Pipeline Products & Ongoing Clinical Trials Overview
    Table 18: AditxtScore Assay - Type I Diabetes - Product Status
    Table 19: AditxtScore Assay - Type I Diabetes - Product Description
    Table 20: Alfa Wassermann Inc Pipeline Products & Ongoing Clinical Trials Overview
    Table 21: ACE Alera Clinical Chemistry System - Direct A1c Assay - Product Status
    Table 22: ACE Alera Clinical Chemistry System - Direct A1c Assay - Product Description
    Table 23: AmideBio, LLC Pipeline Products & Ongoing Clinical Trials Overview
    Table 24: Diagnostic Test - T1 Diabetes - Product Status
    Table 25: Diagnostic Test - T1 Diabetes - Product Description
    Table 26: Aura Biotechnologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
    Table 27: AURA Quant Glargine ELISA Kit - Product Status
    Table 28: AURA Quant Glargine ELISA Kit - Product Description
    Table 29: AURA Quant Human C-peptide Kit - Product Status
    Table 30: AURA Quant Human C-peptide Kit - Product Description
    Table 31: AURA Quant Human Insulin ELISA Kit - Product Status
    Table 32: AURA Quant Human Insulin ELISA Kit - Product Description
    Table 33: Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview
    Table 34: AU480 Clinical System - Next Generation HbA1c Assay - Product Status
    Table 35: AU480 Clinical System - Next Generation HbA1c Assay - Product Description
    Table 36: AU5810 Clinical System - Next-generation HbA1c Assay - Product Status
    Table 37: AU5810 Clinical System - Next-generation HbA1c Assay - Product Description
    Table 38: AU5820 Clinical System - Next-generation HbA1c Assay - Product Status
    Table 39: AU5820 Clinical System - Next-generation HbA1c Assay - Product Description
    Table 40: AU5830 Clinical System - Next-generation HbA1c Assay - Product Status
    Table 41: AU5830 Clinical System - Next-generation HbA1c Assay - Product Description
    Table 42: AU5840 Clinical System - Next-generation HbA1c Assay - Product Status
    Table 43: AU5840 Clinical System - Next-generation HbA1c Assay - Product Description
    Table 44: AU680 Clinical System - Next-generation HbA1c Assay - Product Status
    Table 45: AU680 Clinical System - Next-generation HbA1c Assay - Product Description
    Table 46: Biocrates Life Sciences AG Pipeline Products & Ongoing Clinical Trials Overview
    Table 47: Diagnostic Assay - Type 2 Diabetes - Product Status
    Table 48: Diagnostic Assay - Type 2 Diabetes - Product Description
    Table 49: BioDesign Institute at Arizona State University Pipeline Products & Ongoing Clinical Trials Overview
    Table 50: Biomarker Test - Type 1 Diabetes - Product Status
    Table 51: Biomarker Test - Type 1 Diabetes - Product Description
    Table 52: CellCarta Precision Medicine Inc Pipeline Products & Ongoing Clinical Trials Overview
    Table 53: Diagnostic Assay - Gestational Diabetes Progression - Product Status
    Table 54: Diagnostic Assay - Gestational Diabetes Progression - Product Description
    Table 55: Diagnostic Assay - Islet Cell Health - Product Status
    Table 56: Diagnostic Assay - Islet Cell Health - Product Description
    Table 57: Confer Health Inc Pipeline Products & Ongoing Clinical Trials Overview
    Table 58: Diagnostic Panel - Diabetes - Product Status
    Table 59: Diagnostic Panel - Diabetes - Product Description
    Table 60: Drexel University Pipeline Products & Ongoing Clinical Trials Overview
    Table 61: Diagnostic Assay - Diabetic Ulcers - Product Status
    Table 62: Diagnostic Assay - Diabetic Ulcers - Product Description
    Table 63: ELITechGroup Inc Pipeline Products & Ongoing Clinical Trials Overview
    Table 64: Eon Hemoglobin A1c Assay - Product Status
    Table 65: Eon Hemoglobin A1c Assay - Product Description
    Table 66: Enable Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
    Table 67: ADAP Type1 Diabetes Assay - Product Status
    Table 68: ADAP Type1 Diabetes Assay - Product Description
    Table 69: DBS T1D Autoantibody Assay - Product Status
    Table 70: DBS T1D Autoantibody Assay - Product Description
    Table 71: FibroStatin SL Pipeline Products & Ongoing Clinical Trials Overview
    Table 72: EMTEST - Type 2 Diabetes - Product Status
    Table 73: EMTEST - Type 2 Diabetes - Product Description
    Table 74: G Medical Innovations Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview
    Table 75: HbA1c Test - Product Status
    Table 76: HbA1c Test - Product Description
    Table 77: GATC DB Care Corp Pipeline Products & Ongoing Clinical Trials Overview
    Table 78: Predictive Test - Type 2 Diabetes - Product Status
    Table 79: Predictive Test - Type 2 Diabetes - Product Description
    Table 80: Gelteq Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
    Table 81: Diabetes Screening Kit - Product Status
    Table 82: Diabetes Screening Kit - Product Description
    Table 83: Genesis Detection Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
    Table 84: Rapid Home Test - Hemoglobin A1c - Product Status
    Table 85: Rapid Home Test - Hemoglobin A1c - Product Description
    Table 86: Guangzhou Wondfo Biotech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
    Table 87: Accre Diagnostic Assay - C-peptide - Product Status
    Table 88: Accre Diagnostic Assay - C-peptide - Product Description
    Table 89: Accre Diagnostic Assay - Copeptin - Product Status
    Table 90: Accre Diagnostic Assay - Copeptin - Product Description
    Table 91: Accre Diagnostic Assay - Insulin - Product Status
    Table 92: Accre Diagnostic Assay - Insulin - Product Description
    Table 93: Helmholtz Centre for Infection Research Pipeline Products & Ongoing Clinical Trials Overview
    Table 94: Biomarker Test - Type 2 Diabetes - Product Status
    Table 95: Biomarker Test - Type 2 Diabetes - Product Description
    Table 96: Hemex Health Inc Pipeline Products & Ongoing Clinical Trials Overview
    Table 97: HemeChip - Hemoglobin A1C Test - Product Status
    Table 98: HemeChip - Hemoglobin A1C Test - Product Description
    Table 99: Human Cell Design SAS Pipeline Products & Ongoing Clinical Trials Overview
    Table 100: Type I Diabetes Assay - Product Status
    Table 101: Type I Diabetes Assay - Product Description
    Table 102: Type II Diabetes Assay - Product Status
    Table 103: Type II Diabetes Assay - Product Description
    Table 104: IntraMed Diagnostics, LLC Pipeline Products & Ongoing Clinical Trials Overview
    Table 105: Point-Of-Care Diagnostic Assay - HbA1c - Product Status
    Table 106: Point-Of-Care Diagnostic Assay - HbA1c - Product Description
    Table 107: Janssen Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
    Table 108: Diagnostic Biomarker - Beta-cell Function - Product Status
    Table 109: Diagnostic Biomarker - Beta-cell Function - Product Description
    Table 110: Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
    Table 111: Screening Test - Gestational Diabetes - Product Status
    Table 112: Screening Test - Gestational Diabetes - Product Description
    Table 113: L2 Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
    Table 114: Droplet Digital PCR Assay - Type I Diabetes Mellitus - Product Status
    Table 115: Droplet Digital PCR Assay - Type I Diabetes Mellitus - Product Description
    Table 116: Matter Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
    Table 117: Type 1 Diabetes Prediction And Screening Test - Product Status
    Table 118: Type 1 Diabetes Prediction And Screening Test - Product Description
    Table 119: MediSure Canada Inc Pipeline Products & Ongoing Clinical Trials Overview
    Table 120: At-Home Diagnostic Test - Diabetes Management - Product Status
    Table 121: At-Home Diagnostic Test - Diabetes Management - Product Description
    Table 122: Mellitus LLC Pipeline Products & Ongoing Clinical Trials Overview
    Table 123: Blood Test - Gestational Diabetes - Product Status
    Table 124: Blood Test - Gestational Diabetes - Product Description
    Table 125: Numares AG Pipeline Products & Ongoing Clinical Trials Overview
    Table 126: Diagnostic Test - Diabetes - Product Status(Numares AG)
    Table 127: Diagnostic Test - Diabetes - Product Description(Numares AG)
    Table 128: Peri Rx Inc Pipeline Products & Ongoing Clinical Trials Overview
    Table 129: SaliMark D2 - Product Status
    Table 130: SaliMark D2 - Product Description
    Table 131: PortaScience Inc Pipeline Products & Ongoing Clinical Trials Overview
    Table 132: HbA1c Blood Test - Product Status
    Table 133: HbA1c Blood Test - Product Description
    Table 134: Precision Diabetes LLC Pipeline Products & Ongoing Clinical Trials Overview
    Table 135: Precision IGT Prediabetes Test - Product Status
    Table 136: Precision IGT Prediabetes Test - Product Description
    Table 137: Protagen AG Pipeline Products & Ongoing Clinical Trials Overview
    Table 138: Diagnostic Assay - Type 1 Diabetes - Product Status
    Table 139: Diagnostic Assay - Type 1 Diabetes - Product Description
    Table 140: Queen Mary University of London Pipeline Products & Ongoing Clinical Trials Overview
    Table 141: Biomarker Assay - Type I Diabetes - Product Status
    Table 142: Biomarker Assay - Type I Diabetes - Product Description
    Table 143: QuickCheck Health Inc Pipeline Products & Ongoing Clinical Trials Overview
    Table 144: Diagnostic Test - A1c - Product Status
    Table 145: Diagnostic Test - A1c - Product Description
    Table 146: Sebia SA Pipeline Products & Ongoing Clinical Trials Overview
    Table 147: Capillarys 3 Tera - HbA1c Capillary Blood Assay - Product Status
    Table 148: Capillarys 3 Tera - HbA1c Capillary Blood Assay - Product Description
    Table 149: Sera Prognostics Inc Pipeline Products & Ongoing Clinical Trials Overview
    Table 150: Biomarker Test - Gestational Diabetes Mellitus - Product Status
    Table 151: Biomarker Test - Gestational Diabetes Mellitus - Product Description
    Table 152: Singulex Inc Pipeline Products & Ongoing Clinical Trials Overview
    Table 153: SMC Adiponectin Test - Product Status
    Table 154: SMC Adiponectin Test - Product Description
    Table 155: SomaLogic Inc Pipeline Products & Ongoing Clinical Trials Overview
    Table 156: SomaSignal Test - Diabetic Status - Product Status
    Table 157: SomaSignal Test - Diabetic Status - Product Description
    Table 158: The Forsyth Institute Pipeline Products & Ongoing Clinical Trials Overview
    Table 159: Saliva Based Diagnostic Assay - Type 2 Diabetes - Product Status
    Table 160: Saliva Based Diagnostic Assay - Type 2 Diabetes - Product Description
    Table 161: University of Canterbury Pipeline Products & Ongoing Clinical Trials Overview
    Table 162: Low Intensity Model Based Test - Insulin Resistance - Product Status
    Table 163: Low Intensity Model Based Test - Insulin Resistance - Product Description
    Table 164: University of Colorado Pipeline Products & Ongoing Clinical Trials Overview
    Table 165: IGRP Autoantibody Based Assay - Type-1 Diabetes - Product Status
    Table 166: IGRP Autoantibody Based Assay - Type-1 Diabetes - Product Description
    Table 167: University of Florida Pipeline Products & Ongoing Clinical Trials Overview
    Table 168: Diagnostic Assay - Diabetes - Product Status
    Table 169: Diagnostic Assay - Diabetes - Product Description
    Table 170: University of Newcastle Pipeline Products & Ongoing Clinical Trials Overview
    Table 171: Needle-Free Diabetes Test - Product Status
    Table 172: Needle-Free Diabetes Test - Product Description
    Table 173: University of Oxford Pipeline Products & Ongoing Clinical Trials Overview
    Table 174: Diagnostic Test - Gestational Diabetes - Product Status
    Table 175: Diagnostic Test - Gestational Diabetes - Product Description
    Table 176: University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
    Table 177: Saliva Based Biomarker Assay - Diabetes - Product Status
    Table 178: Saliva Based Biomarker Assay - Diabetes - Product Description
    Table 179: University of Strathclyde Pipeline Products & Ongoing Clinical Trials Overview
    Table 180: Saliva Test - Diabetes Monitoring - Product Status
    Table 181: Saliva Test - Diabetes Monitoring - Product Description
    Table 182: Vactech Oy Pipeline Products & Ongoing Clinical Trials Overview
    Table 183: Type 1 Diabetes Diagnostic Test - Product Status
    Table 184: Type 1 Diabetes Diagnostic Test - Product Description
    Table 185: Wave 80 Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
    Table 186: RAABET T1D Assay - Product Status
    Table 187: RAABET T1D Assay - Product Description
    Table 188: Xhale Inc Pipeline Products & Ongoing Clinical Trials Overview
    Table 189: Oral Glucose Tolerance Test - Product Status
    Table 190: Oral Glucose Tolerance Test - Product Description
    Table 191: Yaathum Biotech Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
    Table 192: Diagnostic Test - Diabetes - Product Status(Yaathum Biotech Pvt Ltd)
    Table 193: Diagnostic Test - Diabetes - Product Description(Yaathum Biotech Pvt Ltd)
    Table 194: Glossary
    2.2 List of Figures
    Figure 1: Diabetes Assays - Pipeline Products by Stage of Development
    Figure 2: Diabetes Assays - Pipeline Products by Segment
    Figure 3: Diabetes Assays - Pipeline Products by Territory
    Figure 4: Diabetes Assays - Pipeline Products by Regulatory Path
    Figure 5: Diabetes Assays - Pipeline Products by Estimated Approval Date

    $4,000
    $8,000
    $12,000

    Research Assistance

    US: 800.298.5699
    Int'l: +1.240.747.3093
    Live help
    Download our eBook: How to Succeed Using Market Research

    Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

    Download eBook

    Other tasks

    Cookie Settings